Arvind Ingle

1.9k total citations
76 papers, 1.4k citations indexed

About

Arvind Ingle is a scholar working on Molecular Biology, Oncology and Biophysics. According to data from OpenAlex, Arvind Ingle has authored 76 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Molecular Biology, 15 papers in Oncology and 14 papers in Biophysics. Recurrent topics in Arvind Ingle's work include Spectroscopy Techniques in Biomedical and Chemical Research (14 papers), Spectroscopy and Chemometric Analyses (12 papers) and Molecular Biology Techniques and Applications (9 papers). Arvind Ingle is often cited by papers focused on Spectroscopy Techniques in Biomedical and Chemical Research (14 papers), Spectroscopy and Chemometric Analyses (12 papers) and Molecular Biology Techniques and Applications (9 papers). Arvind Ingle collaborates with scholars based in India, United States and United Kingdom. Arvind Ingle's co-authors include Girish B. Maru, Shailesh S. Deshpande, John P. Sundberg, Joongho Joh, Rajiv D. Kalraiya, Sharada Sawant, S. Ghim, C. Murali Krishna, Rachana Patel and Milind M. Vaidya and has published in prestigious journals such as PLoS ONE, Cancer Research and Scientific Reports.

In The Last Decade

Arvind Ingle

69 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Arvind Ingle India 24 659 249 221 211 158 76 1.4k
Binghui Li China 23 1.2k 1.9× 173 0.7× 134 0.6× 196 0.9× 66 0.4× 54 1.8k
Woei‐Jer Chuang Taiwan 25 779 1.2× 158 0.6× 175 0.8× 115 0.5× 29 0.2× 75 1.8k
Young‐Jin Kim South Korea 18 635 1.0× 82 0.3× 121 0.5× 349 1.7× 44 0.3× 54 1.2k
Mark A. Hancock Canada 25 1.2k 1.8× 116 0.5× 234 1.1× 299 1.4× 52 0.3× 53 2.2k
David A. Leonard United States 26 800 1.2× 150 0.6× 110 0.5× 127 0.6× 538 3.4× 76 2.0k
Ji-Yun Kim South Korea 19 727 1.1× 131 0.5× 136 0.6× 53 0.3× 55 0.3× 39 1.5k
Zhiyong Ding China 17 966 1.5× 113 0.5× 122 0.6× 173 0.8× 29 0.2× 38 1.6k
Jiafeng Liu China 15 548 0.8× 75 0.3× 95 0.4× 53 0.3× 157 1.0× 60 1.3k
Yunfeng Gao China 16 895 1.4× 69 0.3× 238 1.1× 175 0.8× 42 0.3× 34 1.5k
Anabelle Decottignies Belgium 32 2.3k 3.5× 380 1.5× 117 0.5× 733 3.5× 194 1.2× 66 3.6k

Countries citing papers authored by Arvind Ingle

Since Specialization
Citations

This map shows the geographic impact of Arvind Ingle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arvind Ingle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arvind Ingle more than expected).

Fields of papers citing papers by Arvind Ingle

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arvind Ingle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arvind Ingle. The network helps show where Arvind Ingle may publish in the future.

Co-authorship network of co-authors of Arvind Ingle

This figure shows the co-authorship network connecting the top 25 collaborators of Arvind Ingle. A scholar is included among the top collaborators of Arvind Ingle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arvind Ingle. Arvind Ingle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
3.
Kode, Jyoti, Madan Barkume, Nirmal Kumar Kasinathan, et al.. (2022). A Rationally Designed Bimetallic Platinum (II)‐Ferrocene Antitumor Agent Induces Non‐Apoptotic Cell Death and Exerts in Vivo Efficacy. Chemistry - A European Journal. 28(46). e202201259–e202201259. 25 indexed citations
4.
Rane, Pallavi, Sadhana Kannan, Arvind Ingle, et al.. (2022). Prevention of carcinogen-induced oral cancers by polymeric black tea polyphenols via modulation of EGFR-Akt-mTOR pathway. Scientific Reports. 12(1). 14516–14516. 6 indexed citations
5.
Thorat, Rahul & Arvind Ingle. (2021). Cryopreservation of mouse embryo using vitrification method. 4(1). 7–12.
7.
Soni, Vivek, Arvind Ingle, Bhabani Mohanty, et al.. (2018). Osteogenic Nanofibrous Coated Titanium Implant Results in Enhanced Osseointegration: In Vivo Preliminary Study in a Rabbit Model. Tissue Engineering and Regenerative Medicine. 15(2). 231–247. 13 indexed citations
9.
Sawant, Sharada, Harsh Dongre, Milind M. Vaidya, et al.. (2015). Prognostic role of Oct4, CD44 and c-Myc in radio–chemo-resistant oral cancer patients and their tumourigenic potential in immunodeficient mice. Clinical Oral Investigations. 20(1). 43–56. 59 indexed citations
10.
Sundberg, John P., Timothy M. Stearns, Joongho Joh, et al.. (2014). Immune Status, Strain Background, and Anatomic Site of Inoculation Affect Mouse Papillomavirus (MmuPV1) Induction of Exophytic Papillomas or Endophytic Trichoblastomas. PLoS ONE. 9(12). e113582–e113582. 48 indexed citations
11.
Joh, Joongho, A. Bennett Jenson, Arvind Ingle, John P. Sundberg, & Shin‐je Ghim. (2014). Searching for the initiating site of the major capsid protein to generate virus-like particles for a novel laboratory mouse papillomavirus. Experimental and Molecular Pathology. 96(2). 155–161. 9 indexed citations
12.
Savanur, Mohammed Azharuddin, Radha Pujari, Chen Chen, et al.. (2014). Sclerotium rolfsii Lectin Induces Stronger Inhibition of Proliferation in Human Breast Cancer Cells than Normal Human Mammary Epithelial Cells by Induction of Cell Apoptosis. PLoS ONE. 9(11). e110107–e110107. 29 indexed citations
13.
Bhattacharjee, Tanmoy, Piyush Kumar, Girish B. Maru, Arvind Ingle, & C. Murali Krishna. (2013). Swiss bare mice: a suitable model for transcutaneous in vivo Raman spectroscopic studies of breast cancer. Lasers in Medical Science. 29(1). 325–333. 34 indexed citations
14.
Ingle, Arvind, et al.. (2012). Metastatic behavior of human tumour xenografts in immuno-compromised mouse model. Indian Journal of Veterinary Pathology. 36(2). 192–197.
15.
Ingle, Arvind, et al.. (2010). Use of immuno-compromised mouse model for establishment and study of human animal tumours.. Indian Journal of Veterinary Pathology. 34(2). 156–161. 1 indexed citations
16.
Kundu, Samrat T., Prajakta Gosavi, Nileema Khapare, et al.. (2008). Plakophilin3 downregulation leads to a decrease in cell adhesion and promotes metastasis. International Journal of Cancer. 123(10). 2303–2314. 77 indexed citations
17.
Menon, Lata G., et al.. (2002). Tumor Regression of B16F10 Melanoma in vivo by Prevention of Neovascularization: Study on Theophylline. Cancer Biotherapy and Radiopharmaceuticals. 17(2). 213–217. 5 indexed citations
18.
Ingle, Arvind, et al.. (1999). In Vitro And In Vivo Studies Of Nicotinic Acid In An Experimental Metastasis Model Of B16F10 Melanoma. Indian Journal of Pharmaceutical Sciences. 61(5). 287. 1 indexed citations
19.
Deshpande, Shailesh S., et al.. (1998). Subchronic oral toxicity of turmeric and ethanolic turmeric extract in female mice and rats. Toxicology Letters. 95(3). 183–193. 49 indexed citations
20.
Ingle, Arvind, et al.. (1997). Combination of melatonin and tamoxifen as a chemoprophylaxis against N-nitroso-N-methylurea-induced rat mammary tumors. Cancer Letters. 111(1-2). 59–66. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026